| Immunosuppression for hyperinflammation in COVID-19: a double-edged sword AI Ritchie, A Singanayagam Lancet 395 (10230), 1111, 2020 | 318 | 2020 |
| Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations AI Ritchie, JA Wedzicha Clinics in chest medicine 41 (3), 421-438, 2020 | 274 | 2020 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Therapeutic advances in respiratory disease 10 (2), 158-174, 2016 | 197 | 2016 |
| Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK A Abbara, S Chitty, JK Roe, R Ghani, SM Collin, A Ritchie, OM Kon, ... BMC Infectious Diseases 17, 1-9, 2017 | 139 | 2017 |
| Pathogenesis of viral infection in exacerbations of airway disease AI Ritchie, HA Farne, A Singanayagam, DJ Jackson, P Mallia, ... Annals of the American Thoracic Society 12 (Supplement 2), S115-S132, 2015 | 107 | 2015 |
| Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae LJ Finney, A Ritchie, E Pollard, SL Johnston, P Mallia International journal of chronic obstructive pulmonary disease, 1119-1132, 2014 | 103 | 2014 |
| Airway epithelial orchestration of innate immune function in response to virus infection. A focus on asthma AI Ritchie, DJ Jackson, MR Edwards, SL Johnston Annals of the American Thoracic Society 13 (Supplement 1), S55-S63, 2016 | 66 | 2016 |
| Role of microbiome in the pathophysiology and disease course of asthma A Singanayagam, AI Ritchie, SL Johnston Current Opinion in Pulmonary Medicine 23 (1), 41-47, 2017 | 40 | 2017 |
| Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care PL Shah, CM Orton, B Grinsztejn, GC Donaldson, BC Ramírez, J Tonkin, ... The Lancet Respiratory Medicine 11 (5), 415-424, 2023 | 32 | 2023 |
| Repurposing existing drugs for the treatment of COVID-19 H Farne, K Kumar, AI Ritchie, LJ Finney, SL Johnston, A Singanayagam Annals of the American Thoracic Society 17 (10), 1186-1194, 2020 | 24 | 2020 |
| Pleural epithelioid hemangioendothelioma: literature summary and novel case report J Salijevska, R Watson, A Clifford, AI Ritchie, F Mauri, D Adeboyeku Journal of Clinical Medicine Research 7 (7), 566, 2015 | 23 | 2015 |
| β2-Agonists Enhance Asthma-Relevant Inflammatory Mediators in Human Airway Epithelial Cells AI Ritchie, A Singanayagam, E Wiater, MR Edwards, M Montminy, ... American Journal of Respiratory Cell and Molecular Biology 58 (1), 128-132, 2018 | 21 | 2018 |
| Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study TM Kole, EV Berghe, M Kraft, JM Vonk, MC Nawijn, S Siddiqui, K Sun, ... The Lancet Respiratory Medicine 11 (1), 55-64, 2023 | 20 | 2023 |
| Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study TM Rawson, A Abbara, K Kranzer, A Ritchie, J Milburn, T Brown, ... Respiratory Medicine 120, 101-108, 2016 | 20 | 2016 |
| Virus-induced volatile organic compounds are detectable in exhaled breath during pulmonary infection F Kamal, S Kumar, MR Edwards, K Veselkov, I Belluomo, T Kebadze, ... American Journal of Respiratory and Critical Care Medicine 204 (9), 1075-1085, 2021 | 18 | 2021 |
| Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis A Singanayagam, K Manalan, DW Connell, JD Chalmers, S Sridhar, ... The International Journal of Tuberculosis and Lung Disease 20 (12), 1653-1660, 2016 | 17 | 2016 |
| The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016; 10 (2): 158–74 R Hewitt, H Farne, A Ritchie, E Luke, SL Johnston, P Mallia Thorax 69 (3), 247-53, 2014 | 11 | 2014 |
| Lung-function trajectories: relevance and implementation in clinical practice E Melén, R Faner, JP Allinson, D Bui, A Bush, A Custovic, ... The Lancet, 2024 | 8 | 2024 |
| Targeted retreatment of incompletely recovered chronic obstructive pulmonary disease exacerbations with ciprofloxacin. A double-blind, randomized, placebo-controlled … AI Ritchie, SE Brill, BH Vlies, LJ Finney, JP Allinson, L Alves-Moreira, ... American journal of respiratory and critical care medicine 202 (4), 549-557, 2020 | 8 | 2020 |
| Structural predictors of lung function decline in young smokers with normal spirometry AI Ritchie, GC Donaldson, EA Hoffman, JP Allinson, CI Bloom, CE Bolton, ... American journal of respiratory and critical care medicine, 2024 | 7 | 2024 |
